Nicotine-Induced Norepinephrine Release in Hypothalamic Paraventricular Nucleus and Amygdala Is Mediated by N-Methyl-d-aspartate Receptors and Nitric Oxide in the Nucleus Tractus Solitarius
Authors:
- Rongjie ZhaoRZRongjie Zhao
- Hao ChenHCHao Chen
- Burt M. SharpBSBurt M. Sharp
- 1 February 2007
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 320 (2) , 837-844
Abstract
The noradrenergic projections from brainstem nucleus tractus solitarius (NTS) to hypothalamic paraventricular nucleus (PVN) and amygdala (AMYG) are involved in nicotine-related stress responses and drug craving. Previous studies demonstrated that i.v. nicotine-induced norepinephrine (NE) release in the PVN and AMYG depends on nicotinic cholinergic receptors in the brainstem. However, the direct site and mechanism of nicotine's action in brainstem are unknown. The present study determined the roles of NTS ionotropic glutamate receptors and nitric oxide (NO) in the effects of both local and systemic nicotine on NE release in PVN and AMYG. In male rats, an intra-NTS microinjection of nicotine (1.2 μg free base) or i.v. nicotine infusion (0.065 or 0.09 mg/kg) significantly increased NE levels in PVN and AMYG microdialysates. Prior microinjection of the N-methyl-d-aspartate (NMDA) receptor antagonist, dl-2-amino-5-phosphonopentanoic acid (0.75 or 1.5 μg), but not an α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonist, dose dependently nearly abolished both PVN and AMYG NE responses to nicotine administered into NTS or systemically. NO involvement was assessed with intra-NTS microinjections of the nonselective nitric oxide synthase inhibitor, NG-nitro-l-arginine methyl ester hydrochloride (10–30 nmol), or the NO scavenger, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (0.1–0.2 nmol); both agents dose dependently inhibited i.v. nicotine-induced NE release. These results indicate that nicotine-induced NE release in PVN and AMYG is mediated entirely through the local effects of nicotine on NTS glutamate afferents and NMDA receptors that, in part, stimulate NO production, resulting in activation of noradrenergic neurons. Therefore, nicotine acts indirectly on noradrenergic NTS neurons to elicit NE release in forebrain structures.Keywords
This publication has 44 references indexed in Scilit:
- Nicotine Induces Glutamate Release from Thalamocortical Terminals in Prefrontal CortexNeuropsychopharmacology, 2003
- Neuroimmune Stress Responses: Reciprocal Connections Between the Hypothalamus and the BrainstemStress, 2003
- Nicotine administration stimulates the in vivo N‐methyl‐D‐aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate releaseBritish Journal of Pharmacology, 1998
- Nicotinic acetylcholine receptors in the rat and primate nucleus tractus solitarius and on rat and human inferior vagal (nodose) ganglia: evidence from in vivo microdialysis and [125I]α-bungarotoxin autoradiographyNeuroscience, 1998
- Adrenocorticotropin Response and Nicotine-Induced Norepinephrine Secretion in the Rat Paraventricular Nucleus Are Mediated through Brainstem ReceptorsEndocrinology, 1997
- Norepinephrine Release in the Amygdala in Response to Footshock StimulationNeurobiology of Learning and Memory, 1996
- Amygdala activity at encoding correlated with long-term, free recall of emotional information.Proceedings of the National Academy of Sciences, 1996
- Immunohistochemical Lòcalization of Neuropeptides and Neurotransmitters in the Nucleus SolitariusChemical Senses, 1996
- Nitric oxide induces neurotransmitter release from hippocampal slicesEuropean Journal of Pharmacology, 1992
- Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagusNeurochemistry International, 1985